[1]
“Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors ”, Rev Diabet Stud, vol. 5, no. 2, Aug. 2023, Accessed: Feb. 01, 2026. [Online]. Available: https://diabeticstudies.org/index.php/RDS/article/view/287